Humatica advises the Riverside Company on their recent investment in Alter Pharma

ndetails

Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships

Humatica provided organisational due diligence services for this transaction.

To view press release: Humatica Advisor to Riverside for AlterPharma

Related News

Humatica supports HVD Partners with sale of Solifos AG
10 Dec, 2020 By Humatica

Humatica supports HVD Partners with sale of Solifos AG

Humatica, the leading private equity specialist advisor for portfolio organizational effectiveness, is proud to have supported HVD Partners and the Solifos AG management with the…

Read more arrowicon
InFocus – December 2020 – Boosting Sales Efficiency post-COVID
10 Dec, 2020 By Humatica

InFocus – December 2020 – Boosting Sales Efficiency post-COVID

Is your Sales Force ready for digital sales? As 2020 draws to a close, corporate leaders are looking back over the last months since COVID…

Read more arrowicon
Restructuring: More than Cost-Cutting
26 Nov, 2020 By Humatica

Restructuring: More than Cost-Cutting

Humatica is featured in The Times of London on restructuring for future growth during COVID. The Raconteur supplement on Business Restructuring addresses key aspects on the…

Read more arrowicon